These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31633263)

  • 1. Age, height, BMI and FBG predict prostate volume in ageing benign prostatic hyperplasia: Evidence from 5285 patients.
    Meng J; Liu Y; Guan SY; Ma H; Zhang X; Fan S; Hu H; Zhang M; Liang C
    Int J Clin Pract; 2019 Oct; ():e13438. PubMed ID: 31633263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between serum indirect bilirubin and prostate volume in patients with benign prostatic hyperplasia: a cross-sectional study.
    Ling C; Wu X; Huang W; Pang A; Wu Y; Wang X; Zhang C; Tian Y
    Ann Transl Med; 2022 Oct; 10(20):1127. PubMed ID: 36388836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing clinical parameters of abnormal and normal fasting blood glucose in benign prostatic hyperplasia patients.
    Zhao MJ; Huang Q; Wang XH; Ren XY; Jin YH; Zeng XT
    Aging Male; 2020 Dec; 23(5):655-662. PubMed ID: 30739562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Factors for Tissue Inflammation in Patients with Benign Prostatic Hyperplasia: A Clinical Prediction Study.
    Luo H; Liao G; Wang X; He C; Liu Y
    Urol Int; 2024 Aug; ():1-9. PubMed ID: 39154636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients.
    Li BH; Deng T; Huang Q; Zi H; Weng H; Zeng XT
    Am J Mens Health; 2019; 13(4):1557988319870382. PubMed ID: 31426706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate volume correlates with diabetes in elderly benign prostatic hyperplasia patients.
    Qu X; Huang Z; Meng X; Zhang X; Dong L; Zhao X
    Int Urol Nephrol; 2014 Mar; 46(3):499-504. PubMed ID: 24022843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
    Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP
    BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence and risk factors of prostatic calculi in Han Chinese: a cross-sectional study based on health examinations.
    Meng J; Zhang M; Guan SY; Zhou J; Fan S; Hu H; Liang C
    Aging Male; 2020 Dec; 23(5):887-892. PubMed ID: 31156012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia.
    Mochtar CA; Kiemeney LA; van Riemsdijk MM; Barnett GS; Laguna MP; Debruyne FM; de la Rosette JJ
    Eur Urol; 2003 Dec; 44(6):695-700. PubMed ID: 14644122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.
    Hammarsten J; Högstedt B
    Eur Urol; 2001 Feb; 39(2):151-8. PubMed ID: 11223674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between total/free prostate-specific antigen and prostate volume in Chinese men with biopsy-proven benign prostatic hyperplasia.
    Mao Q; Zheng X; Jia X; Wang Y; Qin J; Yang K; Bai Y; Xie L
    Int Urol Nephrol; 2009 Dec; 41(4):761-6. PubMed ID: 19224388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
    Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
    Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign prostate hyperplasia: average volume in southwestern Nigerians and correlation with anthropometrics.
    Badmus TA; Asaleye CM; Badmus SA; Takure AO; Ibrahim MH; Arowolo OA
    Niger Postgrad Med J; 2012 Mar; 19(1):15-8. PubMed ID: 22430596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.
    Chung BH; Hong SJ; Cho JS; Seong DH
    BJU Int; 2006 Apr; 97(4):742-6. PubMed ID: 16536765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity is associated with larger prostate volume but not with worse urinary symptoms: analysis of a large multiethnic cohort.
    Bhindi B; Margel D; Trottier G; Hamilton RJ; Kulkarni GS; Hersey KM; Finelli A; Trachtenberg J; Zlotta A; Toi A; Evans A; van der Kwast T; Fleshner NE
    Urology; 2014 Jan; 83(1):81-7. PubMed ID: 24044911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of thermobalancing therapy in ageing male with benign prostatic hyperplasia with a focus on etiology and pathophysiology.
    Allen S; Aghajanyan I
    Aging Male; 2017 Mar; 20(1):28-32. PubMed ID: 27960590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population.
    Park JS; Koo KC; Kim HK; Chung BH; Lee KS
    Medicine (Baltimore); 2019 Oct; 98(42):e17635. PubMed ID: 31626149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign prostate hyperplasia: average volume in southwestern Nigerians and correlation with anthropometrics.
    Badmus TA; Asaleye CM; Badmus SA; Takure AO; Ibrahim MH; Arowolo OA
    Niger Postgrad Med J; 2013 Mar; 20(1):52-6. PubMed ID: 23661211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.